InterCure Ltd.
INCR
$1.35
-$0.03-2.17%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.17M | 17.98M | 15.28M | 15.26M | 16.85M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.17M | 17.98M | 15.28M | 15.26M | 16.85M |
| Cost of Revenue | 12.55M | 12.42M | 15.23M | 15.21M | 11.27M |
| Gross Profit | 5.62M | 5.56M | 52.80K | 52.70K | 5.58M |
| SG&A Expenses | 5.77M | 5.71M | 8.60M | 8.59M | 6.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -987.80K | -977.80K | 4.69M | 4.69M | -2.06M |
| Total Operating Expenses | 17.36M | 17.18M | 28.54M | 28.50M | 15.47M |
| Operating Income | 810.40K | 802.10K | -13.26M | -13.25M | 1.38M |
| Income Before Tax | -321.00K | -317.70K | -11.99M | -11.98M | 197.60K |
| Income Tax Expenses | -67.80K | -67.10K | -2.16M | -2.16M | 198.40K |
| Earnings from Continuing Operations | -253.20K | -250.60K | -9.83M | -9.82M | -800.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 15.10K | 14.90K | 480.80K | 480.10K | 192.90K |
| Net Income | -238.10K | -235.70K | -9.35M | -9.34M | 192.10K |
| EBIT | 810.40K | 802.10K | -13.26M | -13.25M | 1.38M |
| EBITDA | 1.99M | 1.97M | -12.61M | -12.69M | 2.23M |
| EPS Basic | 0.00 | 0.00 | -0.21 | -0.21 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.20 | -0.20 | 0.01 |
| EPS Diluted | 0.00 | 0.00 | -0.21 | -0.21 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.20 | -0.20 | 0.01 |
| Average Basic Shares Outstanding | 56.80M | 56.80M | 43.97M | 43.97M | 47.77M |
| Average Diluted Shares Outstanding | 56.80M | 56.80M | 43.97M | 43.97M | 47.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |